💰 Business
Live
Sanofi Raises FY26 Outlook Amid Strong Dupixent Sales
Sanofi’s Q2 net profit fell due to one-time charges, but core business earnings rose 29% driven by Dupixent sales. This operational strength validates its strategic shift, prompting the company to rai
Nasdaq News — 29 July 2026
Text:
44
0
0
Sanofi reported a dramatic drop in its second-quarter net profit to €343 million, down sharply from €3.9 billion a year ago, even as its core business
Read Full Story at Nasdaq News → Sources
💰 Business
Here Is Why Newsmax's Meta Partnership Could Accelerate the Path to Profitability for NMAX Stock.
💰 Business
LIV Golf secures lead investor for player-driven league post-Saudi exit
💰 Business
China exports $163B in goods, threatens AfCFTA industrial projects
💰 Business
US beef prices surge 12% amid drought and cattle shortage
💰 Business
Ahold Delhaize reports Q2 profit drop, reaffirms FY26 growth outlook
💰 Business
Bank of America invests $250 million annually in employee GLP-1 drugs
